COVID-19 Test Project with NGen and Response Biomedical

COVID-19 test development with Ngen and Response Biomedical

Response Biomedical is excited to be a part of Next Generation Manufacturing Canada’s (NGen) fight against COVID-19 by developing a 15 minute COVID-19 test on the RAMP® platform. The RAMP platform technology is a fluorescent-based lateral-flow immunoassay Point of Care (POC) system with Health Canada clearance, proudly manufactured and developed in Vancouver, BC.

We have developed tests for cardiovascular biomarkers such as: D-dimer, Troponin, Procalcitonin, and NT-proBNP, as well as for infectious diseases such as: influenza and respiratory syncytial virus (RSV) for people around the globe. Our goal is to provide a rapid, economical, and accurate COVID-19 diagnostic test for use in point-of-care settings near patients or in your community.

With the support of NGen, we aim to develop and manufacture, at large scale, a RAMP point-of-care test that detects SARS-CoV-2 in 15 minutes or less in patients presenting with symptoms of COVID-19.

Read more about the NGen project and other great Canadian manufacturers taking on the fight against COVID-19 below.


More News


What Is Rapid Testing? A Comprehensive Guide

Learn how rapid testing solutions have become a critical part of patient-centered care programs across the country. Our guide tells your everything you need to know, including how they work, their benefits, how accurate they are, and more.

24 Hour Technical Support Available for all RAMP Customers

Contact Our Specialists

Start Testing Today